Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
Frontiers in Oncology
|
April 4, 2022
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors
David S Hong, Marcus O Butler, Russell K Pachynski, et al.
Oncoimmunology
|
December 15, 2018
Clinical characterization of colitis arising from anti-PD-1 based therapy
Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2021
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
Briana Rose Halle, Allison Betof Warner, Farzana Y Zaman, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Kidney International
|
June 27, 2025
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis
Shruti Gupta, Kavita Mistry, Firasat M Alikhan, et al.
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
European Journal of Cancer (Oxford, England : 1990)
|
December 8, 2024
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
Florentia Dimitriou, Marlana M Orloff, Erica C Koch Hein, et al.
Frontiers in Oncology
|
April 4, 2022
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors
David S Hong, Marcus O Butler, Russell K Pachynski, et al.
Oncoimmunology
|
December 15, 2018
Clinical characterization of colitis arising from anti-PD-1 based therapy
Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2021
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
Briana Rose Halle, Allison Betof Warner, Farzana Y Zaman, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Kidney International
|
June 27, 2025
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis
Shruti Gupta, Kavita Mistry, Firasat M Alikhan, et al.
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2021
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, et al.
Journal for Immunotherapy of Cancer
|
July 6, 2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Prachi Bhave, Tasnia Ahmed, Serigne N Lo, et al.
Page
of 11